![GreenVac_EEA_ project](/en/projects/_/image/5ea8af8d-fae6-4296-8e09-1979e0629286:38e4cbbdfefd06edf22e036756b76175eb79b956/block-800-800/GreenVac_EEA_%20project.jpg?quality=60)
Division of Biotechnology and Plant Health
GreenVac
Development of a cost-effective Romania-Norway joint plant-based technology platform for production of vaccines against human hepatitis viruses B (HBV) and C (HCV)
NIBIO is a project driven research institute and collects approximately 100 million NOK annually in project funding from both national and international sources. A lot of activity is carried out through EU and EEA-projects and we also participate in research projects in Asia, Africa and Latin America. NIBIO coordinates several large international projects with a particular focus on food security and climate change. The list of projects is not complete.
Development of a cost-effective Romania-Norway joint plant-based technology platform for production of vaccines against human hepatitis viruses B (HBV) and C (HCV)